Xi-tao Wang

2 Patents

• US125901542026

  Cancer Immunotherapy by Disrupting PD-1/PD-L1 Signaling

  Bristol-myers Squibb Company

  0 cites
• US121395512024

  Anti-ido Antibody and Uses Thereof

  Bristol-myers Squibb Company

  0 cites